S&P 500   3,183.47 (+0.90%)
DOW   26,565.87 (+1.84%)
QQQ   258.71 (+0.07%)
AAPL   385.86 (+1.03%)
MSFT   206.69 (-0.18%)
FB   237.73 (-0.53%)
AMZN   3,040.23 (-2.05%)
NVDA   413.14 (+2.75%)
CGC   17.23 (-0.40%)
BABA   247.54 (-1.64%)
TSLA   1,505.37 (+0.56%)
T   29.97 (+0.67%)
F   6.32 (+4.12%)
GILD   77.04 (+0.47%)
NFLX   518.50 (-1.33%)
BA   180.09 (+2.53%)
S&P 500   3,183.47 (+0.90%)
DOW   26,565.87 (+1.84%)
QQQ   258.71 (+0.07%)
AAPL   385.86 (+1.03%)
MSFT   206.69 (-0.18%)
FB   237.73 (-0.53%)
AMZN   3,040.23 (-2.05%)
NVDA   413.14 (+2.75%)
CGC   17.23 (-0.40%)
BABA   247.54 (-1.64%)
TSLA   1,505.37 (+0.56%)
T   29.97 (+0.67%)
F   6.32 (+4.12%)
GILD   77.04 (+0.47%)
NFLX   518.50 (-1.33%)
BA   180.09 (+2.53%)
S&P 500   3,183.47 (+0.90%)
DOW   26,565.87 (+1.84%)
QQQ   258.71 (+0.07%)
AAPL   385.86 (+1.03%)
MSFT   206.69 (-0.18%)
FB   237.73 (-0.53%)
AMZN   3,040.23 (-2.05%)
NVDA   413.14 (+2.75%)
CGC   17.23 (-0.40%)
BABA   247.54 (-1.64%)
TSLA   1,505.37 (+0.56%)
T   29.97 (+0.67%)
F   6.32 (+4.12%)
GILD   77.04 (+0.47%)
NFLX   518.50 (-1.33%)
BA   180.09 (+2.53%)
S&P 500   3,183.47 (+0.90%)
DOW   26,565.87 (+1.84%)
QQQ   258.71 (+0.07%)
AAPL   385.86 (+1.03%)
MSFT   206.69 (-0.18%)
FB   237.73 (-0.53%)
AMZN   3,040.23 (-2.05%)
NVDA   413.14 (+2.75%)
CGC   17.23 (-0.40%)
BABA   247.54 (-1.64%)
TSLA   1,505.37 (+0.56%)
T   29.97 (+0.67%)
F   6.32 (+4.12%)
GILD   77.04 (+0.47%)
NFLX   518.50 (-1.33%)
BA   180.09 (+2.53%)
Log in

OTCMKTS:ULGX21st North Stock Price, Forecast & News

$0.0052
0.00 (0.00 %)
(As of 07/14/2020 03:41 PM ET)
Add
Compare
Today's Range
$0.00
Now: $0.01
$0.01
50-Day Range N/A
52-Week Range
$0.00
Now: $0.01
$0.01
Volume60,000 shs
Average Volume55,355 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta2.23
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ULGX
CUSIPN/A
Phone612-475-1400

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees61
Next Earnings DateN/A
OptionableNot Optionable

Receive ULGX News and Ratings via Email

Sign-up to receive the latest news and ratings for ULGX and its competitors with MarketBeat's FREE daily newsletter.

21st North (OTCMKTS:ULGX) Frequently Asked Questions

How has 21st North's stock been impacted by COVID-19 (Coronavirus)?

21st North's stock was trading at $0.0032 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ULGX shares have increased by 62.5% and is now trading at $0.0052. View which stocks have been most impacted by Coronavirus.

Has 21st North been receiving favorable news coverage?

Headlines about ULGX stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. 21st North earned a news impact score of -1.5 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about 21st North.

Who are some of 21st North's key competitors?

What other stocks do shareholders of 21st North own?

Who are 21st North's key executives?

21st North's management team includes the following people:
  • Bryon Merade, Chairman & CEO

What is 21st North's stock symbol?

21st North trades on the OTCMKTS under the ticker symbol "ULGX."

How do I buy shares of 21st North?

Shares of ULGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is 21st North's stock price today?

One share of ULGX stock can currently be purchased for approximately $0.01.

What is 21st North's official website?

The official website for 21st North is www.urologix.com.

How can I contact 21st North?

21st North's mailing address is 14405 21ST AVE N, MINNEAPOLIS MN, 55447. The company can be reached via phone at 612-475-1400 or via email at [email protected]

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.